Product: SPECTRA OPTIA AFERESE SYSTEM. Model: AFERESE SPECTRA OPTIA SYSTEM. Anvisa Registration n ° 80554210002. 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Terumo BCT Tecnologia Médica Ltda; TERUMO BCT INC 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1788
  • 날짜
    2016-01-12
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    According to the company, this possible error does not present risk to the functionality of the equipment. The error may occur in the following circumstances: (1) The user accidentally changes the weight and height values ​​when entering data into the Spectra Optia System; (2) The patient is weighed and measured in units that are different from those selected by the user in the equipment; (3) The user includes inaccurate height and weight data; (4) Abnormal calculation of the patient's total blood volume that may affect the outcome of the procedure.
  • 원인
    Alert on possible error in inclusion of user data records of patient weight and height in the spectra optia system, which would result in the abnormal calculation of the patient's total blood volume.
  • 조치
    This is a safety alert from the company about the correct inclusion of information in the Spectra Optia system. Users should verify the correct entry of information relevant to the safety of the procedure. The TerumoBCT clinical experts were instructed to advise users to double-check the patient's weight and height prior to the start of the procedure. Company code for field action: FA 24

Manufacturer